MANSFIELD, Mass. - March 28, 2008 - Covidien, formerly Tyco Healthcare, was recently notified by its supplier, Scientific Protein Laboratories LLC, of a nation-wide recall of Heparin Sodium USP active pharmaceutical ingredient. The voluntary recall affects 32 lots of Lock Flush Syringe manufactured and distributed by Covidien in the United States.
Covidien began recalling the lots as a precautionary measure due to a notification received from the supplier, Scientific Protein Laboratories, disclosing that two lots of Heparin Sodium USP Active Pharmaceutical Ingredient acquired by Covidien had a heparin-like contaminant.
Covidien has not received any adverse event reports related to this issue. Although a very small product line for Covidien, the Company is committed to following the FDA's lead regarding the heparin recall.
The FDA has received reports of serious injuries and/or deaths in patients who have been administered Heparin injectable products from other companies whose heparin products contained this contaminant.
As indicated in the notification issued by the Scientific Protein Laboratories, typical symptoms include anaphylactic-like reactions such as low blood pressure, shortness of breath, nausea, vomiting, diarrhea, and abdominal pain.
If you or a loved one have been the victim of contaminated heparin and experienced life threatening side effects, stroke or death, please contact Anapol Schwartz law firm so they can evaluate what happened and determine if you/your family are a candidate for a heparin recall lawsuit.
http://www.fda.gov/oc/po/firmrecalls/covidien03_08.html
